title: Necrotizing leukoencephalopathy following CHOP chemotherapy.
abstract: Toxic leukoencephalopathy syndromes are rare disorders of cerebral injury characterized by changes in the white matter and accompanying neurologic dysfunction. They have been reported in association with a variety of clinical etiologies, most commonly including severe hypertension, cranial irradiation, and environmental toxins. However, they have also been described in conjunction with immunosuppressive and chemotherapeutic agents. There has been one case of fatal leukoencephalopathy reported following CHOP chemotherapy for non-Hodgkin lymphoma. We report a second case of fatal necrotizing leukoencephalopathy following the administration of CHOP chemotherapy.
authors: University of Minnesota, Department of Medicine, Division of Hematology/Oncology/Transplantation, United States. blaes004@umn.edu
authors: Anne H
authors: AH
authors: Blaes
authors: Karen S
authors: KS
authors: Santa-Cruz
authors: Chung K K
authors: CK
authors: Lee
authors: Susanta K
authors: SK
authors: Hui
authors: Bruce A
authors: BA
authors: Peterson
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001927:Brain Diseases / Q000209:etiology* / Q000473:pathology*; D002540:Cerebral Cortex / Q000473:pathology; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone